SYNERGY MEGATRON™ Everolimus-Eluting Coronary Stent System

Description

SYNERGY MEGATRON™ combines a robust PtCr stent platform with bioabsorbable abluminal polymer eluting everolimus. The design targets large and complex coronary anatomies, balancing radial strength and deliverability.

• Drug/polymer: abluminal everolimus (~1 μg/mm²). On the largest stent (5.00 × 32 mm), max nominal polymer ≈ 291 μg and drug load ≈ 237 μg.

• Delivery system: 144 cm effective length; single inflation port; guidewire exit ≈ 25 cm from the distal tip; designed for ≤0.014″ (0.36 mm) guidewires.

• Balloon: two radiopaque markers; balloon is nominally 0.4 mm longer than the stent at each end.

• Length change at nominal diameter (avg): SV: 0.15 mm, WH: 0.20 mm, LV: 0.15 mm.

• Inflation pressures: Nominal 11 atm (1117 kPa); RBP 16 atm (1620 kPa).

• Guide catheter compatibility: 3.50–4.00 mm: ≥5F (0.056″/1.42 mm); 4.50–5.00 mm: ≥6F (0.070″/1.78 mm).

• Shaft OD: Proximal 2.1F (0.70 mm); Distal — 3.50 mm (8–20 mm lengths: 2.6F/0.89 mm; 24–32 mm lengths: 2.7F/0.92 mm); 4.00–5.00 mm (8–32 mm lengths: 2.7F/0.92 mm).

Available sizes

• Lengths (mm): 8, 12, 16, 20, 24, 28, 32

• Diameters (mm): 3.50, 4.00, 4.50, 5.00